Google[x] Lab’s Bold Ambition: Pills that can detect cancer

Cancer Pills

The capsule developed by Google[x] is filled with magnetized nanoparticles that are programmed to enter the bloodstream and spot cancerous cell in beginning stages.

Innovations pay off when they make life more apt for people around us in cogent ways. Google[x] innovation lab, devout to finding prodigious solutions to global problems is in the news yet again for a startling disclosure. The semi-secret facility behind innovations such as self-driving cars, stratospheric internet balloons, flying drones, Google Glass, and seamless modular display is now developing a pill that could give off biochemical signals when the person contracts a life threatening disease.

Google’s head of life sciences and molecular biologist, Dr. Andrew Conrad, at the WSJDLive Conference in Laguna Beach, Calif., disclosed that the clandestine Google[x] lab has been developing a pill that could sniff out cancer and other malignant diseases within the human body.

The pill is third in line of health and biotechnology initiatives taken by Google[x] lab, following 1.) A smart contact lens to assist diabetics in monitoring their glucose levels, and 2.) Eating utensils designed to improve the quality of life of people affected by neurodegenerative tremors.

The capsule is filled with minuscule iron-oxide nanoparticles that are programmed to enter the bloodstream and spot cancerous cell in beginning stages. A wearable device worn on the wrist that couples with this nanotechnology, then summons the magnetized nanoparticles to come back and determine cancer or any other potentially life threatening disease.

The project is known as Nanoparticle Platform, and involves creation of magnetic nanoparticles that are thousandth the width of RBC and are coated with antibodies that can beam with molecules, proteins and abnormal cells within the body.

So far, the ambitious project is in exploratory stages and at least four to five years away from being approved for use by medical experts since it requires a much higher regulatory bar compared to conventional diagnostic tools.

“Every test you ever go to the doctor for will be done through this system. That’s our dream.”

Dr Andrew Conrad, head of the Life Sciences team at Google[x].

The U.S. government has invested more than $20 million in nanotechnology research in past ten years. The monitoring pill by Google is more likely to raise eyebrows by critics who fear the company’s Big Brother like approach to track users and handing over the information to the U.S. government.

“We are the inventors of the technology but we have no intentions of commercialising it or monetising it in that way,” Conrad stated. He further mentioned that Google will not collect or store any individual medical data, but will instead license the technology to those who can handle the data and its security.

Up to this point, 100 Google employees with prowess in various fields such as astrophysics, chemistry, electrical engineering, biotechnology have been a part of the pioneering nanotechnology project to develop new diagnostic tools for physicians.

Google is keen on improving transforming the detection, prevention and management of disease into a much easier way using smart devices.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

UK’s Sanne agrees to consider Cinven bid

UK’s Sanne agrees to consider Cinven bid

Sanne, a UK fund administration business that provides alternative asset and corporate services, has agreed to hold talks with private equity firm Cinven over a potential £1.4bn t
6 hours ago
Global stocks rise as investors ignore inflations indicators

Global stocks rise as investors ignore inflations indicators

Global stocks rose to an all-time high, with investor showing confidence in a strong economic recovery from coronavirus and the vaccine effect, but the market is still a bit cautio
6 hours ago
UK watchdog whacks Amazon with probe for unfair data collection practices

UK watchdog whacks Amazon with probe for unfair data collection practices

The Competition and Markets Authority will focus on whether Amazon, Inc. favors merchants that use its delivery services.
3 days ago
Altice buys 12 percent stake in BT worth £2 billion

Altice buys 12 percent stake in BT worth £2 billion

Altice said it did not intend to make a bid for the British Telecoms company, though the takeover code also does not allow it to make an unsolicited buyout offer for six months wit
3 days ago
G7 countries agree on broad principles of minimum corporate tax deal

G7 countries agree on broad principles of minimum corporate tax deal

The world’s richest nations (G7) reached a landmark accord setting a global minimum corporate tax rate for multinationals. Would it be effective in tackling tax evasion and avoid
3 days ago
BC Partner goes the Continuation Fund way to strike a $7bn deal

BC Partner goes the Continuation Fund way to strike a $7bn deal

BC Partners, a UK private equity firm, has floated a “continuation fund” deal, one of Europe’s largest such deals, by transferring its 47 per cent stake in the academic publi
3 days ago